Patent details

EP1341533 Title: Synergetische combinaties die een renineremmer omvatten voor cardiovasculaire ziekten.

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic Information

Publication number:
EP1341533
WO Application Number:
EP2001013241
Type:
European Patent Granted for NL
Status:
Expired. Art. 36.6 ROW
Publication Title:
Title When Made Available For Viewing:
Reason Lapsed:
Application number:
EP01996377.6
WO Publication Number:
WO2002040007
EPO Publication Language:
English
SPC Number:
First Applicant Residence Country:
Switzerland (CH)
Publications:

Dates

Filing date:
15/11/2001
Grant date:
15/02/2006
EP Publication Date:
15/02/2006
WO Publication Date:
Claims Translations Received Date:
Claims Translation B1 Received Date:
Claims Translation B2 Received Date:
Claims Translation B3 Received Date:
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Published:
Due To Cession Date:
Registration date:
15/02/2006
EP B1 Publication Date:
15/02/2006
EP B2 Publication Date:
EP B3 Publication Date:
Description Translation B1 Received Date:
Description Translation B2 Received Date:
Description Translation B3 Received Date:
Expiration date:
14/11/2021
Lapsed By Expiration Date:
15/11/2021
Revocation Date:
Invalidity Date:
Response To Novelty Search Report Received:
Patent Granting Request:
Lapsed date:

Applicant/holder

From:
19/11/2019
 
 

 

Name:
Noden Pharma DAC
Address:
D'Olier Chambers 16A D'Olier Street, Dublin 2, Ireland (IE)

Historical Applicant/holder

From:
19/11/2019
To:
19/11/2019

 

Name:
Noden Pharma DAC
Address:
D'Olier Chambers 16A D'Olier Street, Dublin 2, Ireland (IE)

From:
02/02/2009
To:
15/05/2018

 

Name:
Novartis Pharma AG
Address:
Lichtstrasse 35, 4056, Basel, Switzerland (CH)

From:
15/02/2006
To:
02/02/2009

 

Name:
Novartis AG Patent & Trademark Department.
Address:
Lichtstrasse 35, CH-4002, Bazel, Switzerland (CH)

Domicile Holder

Name:
ir. M.F.J.M. Ketelaars c.s.
From:
15/02/2006
Address:
NLO Postbus 29720, 2502 LS, Den Haag, Netherlands (NL)
To:

Inventor

1

Name:
William HEWITT
Address:
PA 19465, Pottstown, United States of America (US)

2

Name:
Daniel Lucius VASELLA
Address:
CH-4056, Basel, Switzerland (CH)

3

Name:
Randy, Lee WEBB
Address:
NJ 08822, Flemington, United States of America (US)

Priority

Priority Patent Number:
0028151
Priority Date:
17/11/2000
Priority Country:
United Kingdom (GB)

Classification

Main IPC Class:
A61K 31/165;
IPC or IDT classification:
A61P 9/00;

Publication

Bulletin

1

Bulletin Heading:
VRV
Journal edition number:
46/21
Publication date:
17/11/2021
Description:
Lapse or annulment

2

Bulletin Heading:
CO
Journal edition number:
27/18
Publication date:
27/06/2018
Description:
Changes in the Netherlands Patent Register

3

Bulletin Heading:
CO
Journal edition number:
2009/04
Publication date:
01/04/2009
Description:
Changes in the Netherlands Patent Register

4

Bulletin Heading:
MED
Journal edition number:
2006/09
Publication date:
01/09/2006
Description:
Other communications

5

Bulletin Heading:
EP3
Journal edition number:
2006/08
Publication date:
01/08/2006
Description:
European patents granted for the Netherlands in which a translation was filed ex Article 52 par. 1 of the NL Patent Law 1995

6

Bulletin Heading:
EP2
Journal edition number:
2006/04
Publication date:
03/04/2006
Description:
European patents granted for the Netherlands

European Patent Bulletin

Issue number:
200607
Publication date:
15/02/2006
Description:
Grant (B1)

Deed

Change of Address

Change Kind/ Decision Type:
Owner
Deed Number:
RC201902341A
Date Registered:
19/11/2019
License Effective Date:
License Expiration Date:
Scope of License:
Deed Filer:
ir. M.F.J.M. Ketelaars c.s.
Journal Edition Number:
Text:
Deed Status:
Country Code:
Updated License Number:
Terminated License Number:

Changed Pledgee

Name:
Address:

Removed Usufructuary

Name:
Address:

Added Usufructuary

Name:
Address:

Changed Usufructuary

Name:
Address:

Change of owner(s)

Change Kind/ Decision Type:
Assignment
Deed Number:
RC201800928A
Date Registered:
15/05/2018
License Effective Date:
License Expiration Date:
Scope of License:
Deed Filer:
ir. M.F.J.M. Ketelaars c.s.
Journal Edition Number:
Text:
Deed Status:
Country Code:
Updated License Number:
Terminated License Number:

Added Owner(s)

Name:
Noden Pharma DAC
Address:
56 Fitzwilliam Square, Dublin 2 , Ireland (IE)

Changed Pledgee

Name:
Address:

Removed Usufructuary

Name:
Address:

Added Usufructuary

Name:
Address:

Changed Usufructuary

Name:
Address:

Change of owner(s)

Change Kind/ Decision Type:
Assignment
Deed Number:
53067-A053067-1
Date Registered:
02/02/2009
License Effective Date:
License Expiration Date:
Scope of License:
Deed Filer:
ir. M.F.J.M. Ketelaars c.s.
Journal Edition Number:
Text:
Deed Status:
Country Code:
Updated License Number:
Terminated License Number:

Changed Pledgee

Name:
Address:

Removed Usufructuary

Name:
Address:

Added Usufructuary

Name:
Address:

Changed Usufructuary

Name:
Address:

Annual Fee

Annual Fee(s) Due Date:
Annual Fee Number:
Last Annual Payment Date:
13/11/2020
Last Annual Fee Paid Number:
20
Last Annual Fee Paid Amount:
1400 Euro
Payer:
Computer Patent Annuities Limited (CPA)
Filing date Document type Document Description Number of pages File Type
25/06/2018 Outgoing Correspondence Letter registration deed 1 PDF /7/7/3/6/9/0501996377/docs/ep01996377.6_0_214159l118.pdf
15/05/2018 Request for Change First filed deed 28 PDF /7/7/3/6/9/0501996377/docs/ep01996377.6_5_rfc20180517022331336.pdf
15/05/2006 Description Translated description 32 PDF /7/7/3/6/9/0501996377/docs/ep01996377.6_1_description20060515.pdf
15/05/2006 Claims Translated claims 4 PDF /7/7/3/6/9/0501996377/docs/ep01996377.6_2_claims20060515.pdf
15/05/2006 Incoming Correspondence Paper Incoming Correspondence Paper 1 PDF /7/7/3/6/9/0501996377/docs/ep01996377.6_3_incomingcorrespondencepaper20060515.pdf
23/02/2006 Incoming Correspondence Paper Other 1 PDF /7/7/3/6/9/0501996377/docs/ep01996377.6_4_incomingcorrespondencepaper20060223.pdf